Veru Inc is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of diseases, particularly in the areas of oncology and urology. The company is engaged in the research and development of novel drug candidates aimed at addressing unmet medical needs, with a strong emphasis on advancing therapies for prostate cancer and other challenging health conditions. Veru is also involved in the production of specialty pharmaceutical products, showcasing its commitment to improving patient outcomes through scientific innovation and rigorous clinical trials.